Label-free cell separation and purification | Edge Precision

Untitled (3 x 2 in)

What is Deterministic Cell Separation?

Deterministic Cell Separation (DCS) is a label-free, microfluidic way to separate and purify cells by size. As a sample flows through a precisely engineered array of micropillars, larger cells are deterministically displaced along one path while smaller cells and diffusible species follow another. Based on deterministic lateral displacement (DLD), DCS purifies, enriches, and washes cells without antibodies, magnetic beads, or a centrifuge, so cells stay gentle-handled and unactivated. It scales from microliter research volumes to 300+ mL apheresis using the same method.

Choose the device that fits your application

Every DCS device is compatible with off-the-shelf microfluidic controllers and needs only two pressure sources, so you can start separating cells without buying a dedicated instrument.

Critical diameter	Lanes	Example applications	Capacity and throughput
4.3 µm	34	Purifying WBCs from RBCs and platelets	~6.5 mL/min, ~60 mL
4.3 µm	68	Purifying WBCs from RBCs and platelets	~13 mL/min, ~120 mL
5.5 µm	20	Purifying stem cells from WBCs	~4 mL/min, ~40 to 60 mL
6.5 µm	20	Separating lymphocytes from granulocytes and monocytes	~4 mL/min, ~40 to 60 mL
7.5 µm	20	Separating lymphocytes from granulocytes and monocytes	~4 mL/min, ~40 to 60 mL
8.5 µm	20	Isolating tumor-infiltrating lymphocytes from mouse tumors	~4 mL/min, ~40 to 60 mL

As cells flow through a precisely engineered array of micropillars, larger cells follow one path and smaller cells and diffusible species follow another. That physical sorting is what makes DCS label-free and repeatable.

The same principle scales. Parallelized arrays take you from small research volumes up to full apheresis collections without changing the underlying method.

Mathematically defined array geometries are designed for different critical diameters. Choose the one that fits your target cells.

Common questions about DCS

Deterministic lateral displacement (DLD) is the physics behind DCS. In a precisely spaced array of micropillars, particles above a critical size are bumped laterally into a predictable path, while smaller particles follow the fluid streamlines. The result is size-based separation that is continuous, label-free, and repeatable.

Magnetic bead and immunomagnetic methods separate cells by tagging a surface marker with an antibody-coated bead, then pulling the tagged cells out and removing the beads. DCS separates by physical cell size, so there is nothing to tag and nothing to strip back out. That means no antibodies, no beads, no reagent lock-in, and cells that stay label-free.

Yes. Teams use DCS in place of manual Ficoll to isolate white blood cells and PBMCs from blood. Compared with manual Ficoll, DCS gives higher target-cell recovery, strong platelet and red blood cell depletion, and less operator-to-operator variability, with no centrifuge step.

Yes. The same method scales from under 1 mL research volumes up to 300+ mL apheresis collections by running more lanes in parallel. Devices process fresh blood products including whole blood, apheresis, and buffy coats, as well as cultured and expanded cells.

No. DCS devices are compatible with off-the-shelf microfluidic controllers and need only two pressure sources, so you can start without buying a dedicated closed instrument.

DCS catalog devices are available now for Research Use Only, with no minimum order. You can buy a single device or scale throughput with more lanes. For a path toward clinical manufacturing, we co-develop a custom, regulated solution with your team.

Back to top